Global Pharmaceuticals & Biotech Most Popular Stocks

Eli Lilly

Market Cap: US$679.9b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Johnson & Johnson

Market Cap: US$370.2b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

AbbVie

Market Cap: US$312.8b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Novo Nordisk

Market Cap: DKK 1.9t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Roche Holding

Market Cap: CHF 203.9b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Novartis

Market Cap: CHF 171.7b

Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.

AstraZeneca

Market Cap: UK£159.0b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Merck

Market Cap: US$197.3b

Operates as a healthcare company worldwide.

Thermo Fisher Scientific

Market Cap: US$166.5b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Amgen

Market Cap: US$158.8b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Danaher

Market Cap: US$135.9b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Gilead Sciences

Market Cap: US$131.7b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Vertex Pharmaceuticals

Market Cap: US$128.5b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Pfizer

Market Cap: US$127.3b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Sanofi

Market Cap: €110.6b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

Bristol-Myers Squibb

Market Cap: US$101.7b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Chugai Pharmaceutical

Market Cap: JP¥11.1t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

CSL

Market Cap: AU$117.1b

Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

GSK

Market Cap: UK£54.6b

Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Zoetis

Market Cap: US$66.6b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Regeneron Pharmaceuticals

Market Cap: US$59.7b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Merck KGaA

Market Cap: €51.6b

Operates as a science and technology company in Germany.

Samsung BiologicsLtd

Market Cap: ₩72.8t

Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

Sun Pharmaceutical Industries

Market Cap: ₹4.1t

A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally.

Lonza Group

Market Cap: CHF 38.3b

Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

Haleon

Market Cap: UK£34.6b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Takeda Pharmaceutical

Market Cap: JP¥6.4t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Jiangsu Hengrui Medicine

Market Cap: CN¥310.9b

A pharmaceutical company, researches, develops, manufactures, and commercializes drugs in China and internationally.

Daiichi Sankyo Company

Market Cap: JP¥5.9t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

argenx

Market Cap: €31.9b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

UCB

Market Cap: €26.3b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Alnylam Pharmaceuticals

Market Cap: US$29.8b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Agilent Technologies

Market Cap: US$29.4b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

IQVIA Holdings

Market Cap: US$26.3b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

BeiGene

Market Cap: US$25.7b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Otsuka Holdings

Market Cap: JP¥3.5t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.